awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30240043-BFF3A40F-869B-4A77-AB36-E863406E9F66
Q30240043-BFF3A40F-869B-4A77-AB36-E863406E9F66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30240043-BFF3A40F-869B-4A77-AB36-E863406E9F66
How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes.
P2860
Q30240043-BFF3A40F-869B-4A77-AB36-E863406E9F66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30240043-BFF3A40F-869B-4A77-AB36-E863406E9F66
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d437db8a3a319eba3e378a55677e52f8aef3ed0a
P2860
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.